PKD
Polycystic kidney disease is included in the DNA screening used for our breeding cats. We select against affected or at-risk combinations.
No breeder can promise a living animal will never become ill. What we can do is use available testing, veterinary care, thoughtful selection and transparent records to reduce avoidable risk.
Our breeding program uses Wisdom Panel's feline DNA screening, including a 49-disease panel and blood-type information.
Polycystic kidney disease is included in the DNA screening used for our breeding cats. We select against affected or at-risk combinations.
Progressive retinal atrophy is included in the panel. Our tested breeding cats are screened for the relevant mutation.
Blood-type information is part of the genetic data used when planning matings and neonatal care.
A carrier is not the same as an affected animal. Carrier results are used to avoid carrier-to-carrier matings for recessive conditions.
Public Wisdom Panel result links for Boba, Lyra and Orek will be added directly to their profiles; Mia and Nyx are planned so every breeding cat has a public record.
Incoming cats are tested before they are introduced to the established cattery population. FIV/FeLV status, general health, fecal testing and veterinary evaluation are part of protecting the cats already living here.
We also pay close attention to respiratory comfort, nares, bite, skull structure and the total cat—not merely a DNA report.
Himalayans are brachycephalic. We take that seriously rather than pretending the topic does not exist.
We deliberately select away from severely narrowed nostrils and do not want to produce cats that struggle to breathe.
Nares are one visible feature. Breathing comfort, skull structure, bite, activity and veterinary findings all matter.
Good breeding means acknowledging breed-related risks and using current veterinary knowledge to make better choices.